Long non-coding RNA PVT1/microRNA miR-3127-5p/NCK-associated protein 1-like axis participates in the pathogenesis of abdominal aortic aneurysm by regulating vascular smooth muscle cells

References

• Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365(9470):1577–1589.
   PubMed Web of Science ®Google Scholar
• Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol. 2019;16(4):225–242.
   PubMed Web of Science ®Google Scholar
• Lilja F, Wanhainen A, Mani K. Changes in abdominal aortic aneurysm epidemiology. J Cardiovasc Surg (Torino). 2017;58(6):848–853.
   PubMed Web of Science ®Google Scholar
• Tchana-Sato V, Sakalihasan N, Defraigne JO. [Ruptured abdominal aortic aneurysm]. Rev Med Liege. 2018;73(5–6):296–299.
   PubMedGoogle Scholar
• Wang YD, Liu Z-J, Ren J, et al. Pharmacological therapy of abdominal aortic aneurysm: an update. Curr Vasc Pharmacol. 2018;16(2):114–124.
   PubMed Web of Science ®Google Scholar
• Hadi T, Boytard L, Silvestro M, et al. Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells. Nat Commun. 2018;9(1):5022.
   PubMedGoogle Scholar
• Chang Z, Zhao G, Zhao Y, et al. BAF60a deficiency in vascular smooth muscle cells prevents abdominal aortic aneurysm by reducing inflammation and extracellular matrix degradation. Arterioscler Thromb Vasc Biol. 2020;40(10):2494–2507.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jia L, Xie Y, et al. Involvement of macrophage-derived exosomes in abdominal aortic aneurysms development. Atherosclerosis. 2019;289:64–72.
   PubMed Web of Science ®Google Scholar
• Peng H, Zhang K, Liu Z, et al. VPO1 modulates vascular smooth muscle cell phenotypic switch by activating extracellular signal-regulated kinase 1/2 (ERK 1/2) in abdominal aortic aneurysms. J Am Heart Assoc. 2018;7(17):e010069.
   PubMed Web of Science ®Google Scholar
• Tian Z, Sun Y, Sun X, et al. LINC00473 inhibits vascular smooth muscle cell viability to promote aneurysm formation via miR-212-5p/BASP1 axis. Eur J Pharmacol. 2020;873:172935.
   PubMed Web of Science ®Google Scholar
• Zhao L, Ouyang Y, Bai Y, et al. miR-155-5p inhibits the viability of vascular smooth muscle cell via targeting FOS and ZIC3 to promote aneurysm formation. Eur J Pharmacol. 2019;853:145–152.
   PubMed Web of Science ®Google Scholar
• Li X, Li N. LncRNAs on guard. Int Immunopharmacol. 2018;65:60–63.
   PubMed Web of Science ®Google Scholar
• Kumar S, Boon RA, Maegdefessel L, et al. Role of noncoding RNAs in the pathogenesis of abdominal aortic aneurysm. Circ Res. 2019;124(4):619–630.
   PubMed Web of Science ®Google Scholar
• Knappich C, Spin JM, Eckstein -H-H, et al. Involvement of myeloid cells and noncoding RNA in abdominal aortic aneurysm disease. Antioxid Redox Signal. 2020;33(9):602–620.
   PubMed Web of Science ®Google Scholar
• Li DY, Busch A, Jin H, et al. H19 induces abdominal aortic aneurysm development and progression. Circulation. 2018;138(15):1551–1568.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang H, Wang G, et al. LncRNA LBX2-AS1 facilitates abdominal aortic aneurysm through miR-4685-5p/LBX2 feedback loop. Biomed Pharmacother. 2020;129:109904.
   PubMed Web of Science ®Google Scholar
• He X, Wang S, Li M, et al. Long noncoding RNA GAS5 induces abdominal aortic aneurysm formation by promoting smooth muscle apoptosis. Theranostics. 2019;9(19):5558–5576.
   PubMed Web of Science ®Google Scholar
• Cai Z, Huang J, Yang J, et al. LncRNA SENCR suppresses abdominal aortic aneurysm formation by inhibiting smooth muscle cells apoptosis and extracellular matrix degradation. Bosn J Basic Med Sci. 2021;21(3):323–330.
   PubMed Web of Science ®Google Scholar
• Lu D, Luo P, Wang Q, et al. lncRNA PVT1 in cancer: a review and meta-analysis. Clin Chim Acta. 2017;474:1–7.
   PubMed Web of Science ®Google Scholar
• Zhou C, Yi C, Yi Y, et al. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Mol Cancer. 2020;19(1):118.
   PubMed Web of Science ®Google Scholar
• Cho SW, Xu J, Sun R, et al. Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element. Cell. 2018;173(6):1398–1412.e22.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zou G, Chen X, et al. Knockdown of lncRNA PVT1 inhibits vascular smooth muscle cell apoptosis and extracellular matrix disruption in a murine abdominal aortic aneurysm model. Mol Cells. 2019;42(3):218–227.
   PubMed Web of Science ®Google Scholar
• Xiong JM, Liu H, Chen J, et al. Curcumin nicotinate suppresses abdominal aortic aneurysm pyroptosis via lncRNA PVT1/miR-26a/KLF4 axis through regulating the PI3K/AKT signaling pathway. Toxicol Res (Camb). 2021;10(3):651–661.
   PubMed Web of Science ®Google Scholar
• Cook SA, Comrie WA, Poli MC, et al. HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease. Science. 2020;369(6500):202–207.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu M, Guo F, et al. Identification of tumor microenvironment-related prognostic biomarkers in luminal breast cancer. Front Genet. 2020;11:555865.
   PubMed Web of Science ®Google Scholar
• Li H, Bai S, Ao Q, et al. Modulation of immune-inflammatory responses in abdominal aortic aneurysm: emerging molecular targets. J Immunol Res. 2018;2018:7213760.
   PubMed Web of Science ®Google Scholar
• Vandestienne M, Zhang Y, Santos-Zas I, et al. TREM-1 orchestrates angiotensin II-induced monocyte trafficking and promotes experimental abdominal aortic aneurysm. J Clin Invest. 2021;131(2):2.
   Web of Science ®Google Scholar
• Li Z, Kong W. Cellular signaling in abdominal aortic aneurysm. Cell Signal. 2020;70:109575.
   PubMed Web of Science ®Google Scholar
• Castro CN, Rosenzwajg M, Carapito R, et al. NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation. J Exp Med. 2020;217(12):12.
   Web of Science ®Google Scholar
• Liang B, Che J, Zhao H, et al. MiR-195 promotes abdominal aortic aneurysm media remodeling by targeting Smad3. Cardiovasc Ther. 2017;35(6):6.
   Web of Science ®Google Scholar
• Zhao F, Chen T, Jiang N. CDR1as/miR-7/CKAP4 axis contributes to the pathogenesis of abdominal aortic aneurysm by regulating the proliferation and apoptosis of primary vascular smooth muscle cells. Exp Ther Med. 2020;19(6):3760–3766.
   PubMed Web of Science ®Google Scholar
• Yang B, Wang X, Ying C, et al. Long noncoding RNA SNHG16 facilitates abdominal aortic aneurysm progression through the miR-106b-5p/STAT3 feedback loop. J Atheroscler Thromb. 2021;28(1):66–78.
   PubMed Web of Science ®Google Scholar
• Palmaz JC, Kopp DT, Hayashi H, et al. Normal and stenotic renal arteries: experimental balloon-expandable intraluminal stenting. Radiology. 1987;164(3):705–708.
   PubMed Web of Science ®Google Scholar
• Tang D, Zhao D, Wu Y, et al. The miR-3127-5p/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer. J Cell Mol Med. 2018;22(8):3847–3856.
   PubMed Web of Science ®Google Scholar
• Yang J, Hou S, Liang B. LINC00319 promotes migration, invasion and epithelial-mesenchymal transition process in cervical cancer by regulating miR-3127-5p/RPP25 axis. Vitro Cell Dev Biol Anim. 2020;56(2):145–153.
   PubMed Web of Science ®Google Scholar
• Yang Y, Sun Y, Wu Y, et al. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer. Mol Carcinog. 2018;57(7):842–853.
   PubMed Web of Science ®Google Scholar
• Ma Y, Li Y, Tang Y, et al. LINC00174 facilitates proliferation and migration of colorectal cancer cells via MiR-3127-5p/ E2F7 axis. J Microbiol Biotechnol. 2021;31(8):1098–1108.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Wu Q, Zhang M, et al. Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5. Oncol Rep. 2021;45(2):501–512.
   PubMed Web of Science ®Google Scholar
• Iida Y, Xu B, Xuan H, et al. Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression. Arterioscler Thromb Vasc Biol. 2013;33(4):718–726.
   PubMed Web of Science ®Google Scholar
• Batra R, Suh MK, Carson JS, et al. IL-1β (Interleukin-1β) and TNF-α (Tumor Necrosis Factor-α) impact abdominal aortic aneurysm formation by differential effects on macrophage polarization. Arterioscler Thromb Vasc Biol. 2018;38(2):457–463.
   PubMed Web of Science ®Google Scholar
• Jin N, Hatton ND, Harrington MA, et al. H(2)O(2)-induced egr-1, fra-1, and c-jun gene expression is mediated by tyrosine kinase in aortic smooth muscle cells. Free Radic Biol Med. 2000;29(8):736–746.
   PubMed Web of Science ®Google Scholar
• Shi X, Ma W, Li Y, et al. MiR-144-5p limits experimental abdominal aortic aneurysm formation by mitigating M1 macrophage-associated inflammation: suppression of TLR2 and OLR1. J Mol Cell Cardiol. 2020;143:1–14.
   PubMed Web of Science ®Google Scholar
• Zhao L, Huang J, Zhu Y, et al. miR-33-5p knockdown attenuates abdominal aortic aneurysm progression via promoting target adenosine triphosphate-binding cassette transporter A1 expression and activating the PI3K/Akt signaling pathway. Perfusion. 2020;35(1):57–65.
   PubMed Web of Science ®Google Scholar